| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | +95.3% |
| Cost of Revenue | $1.9M | -69.2% |
| Gross Profit | -$893K | +84.4% |
| R&D Expense | $9.6M | -9.4% |
| SG&A Expense | $14.8M | -57.8% |
| Operating Income | -$39.8M | +25.9% |
| Pre-tax Income | -$48.9M | +24.1% |
| Income Tax | $97K | -79.5% |
| Net Income | -$48.2M | +13.0% |
| EPS (Basic) | $11.44 | +499.0% |
| EPS (Diluted) | $11.44 | +499.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $78K | -90.7% |
| Accounts Receivable | $40K | -54.5% |
| Inventory | $34K | +0.0% |
| Current Assets | $761K | -81.3% |
| Total Assets | $1.4M | -90.7% |
| Current Liabilities | $26.9M | +64.1% |
| Total Liabilities | $38.9M | +9.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.1M | -15.1% |
| Capital Expenditures | $263K | -87.5% |
| Investing Cash Flow | $365K | +109.8% |
| Financing Cash Flow | $16.0M | +17.2% |
| Free Cash Flow | -$17.3M | -2.4% |
| Stockholders' Equity |
| -$37.5M |
| -78.7% |